St. John's Research Institute looking for Pharma, Health Sciences
2 March 2026

St. John's Research Institute looking for Pharma, Health Sciences candidates

Master qualification in health sciences, pharmacy or related subject in public health OR with clinical research experience of at least 2 years.
Research positions for Biotechnology / Biochemistry candidate at SCTIMST
2 March 2026
Research positions for Biotechnology / Biochemistry candidate at SCTIMST
MSc Biotechnology / Biochemistry with First Class OR Integrated M.Sc Biotechnology / Biochemistry with First Class.
Recruitment for Chronic Pancreatitis at THSTI - Life Sciences Candidates Eligible
2 March 2026
Recruitment for Chronic Pancreatitis at THSTI - Life Sciences Candidates Eligible
Masters degree in Life sciences / M.V.Sc. from a recognized university. OR B.E / B.Tech. in Computer Science or related field from a recognized University or equivalent.
Ind-Swift Group Hiring Pharmacy graduates to work in Packing and Production
2 March 2026
Ind-Swift Group Hiring Pharmacy graduates to work in Packing and Production

Ind-Swift Group, founded in 1986 and headquartered in Chandigarh, India, is a globally trusted pharmaceutical company recognized for its innovation, quality, and commitment to healthcare excellence. With a legacy built on scientific advancement and ethical practices, we have emerged as a powerful force in both Domestic and Export pharmaceutical markets. 

Ind-Swift Group Hiring

Interview for Production, Packing and Quality Control at Emcure
2 March 2026
Interview for Production, Packing and Quality Control at Emcure
Emcure is fast-growing Indian pharmaceutical company engaged in developing, manufacturing, and marketing a broad range of pharmaceutical products globally
Requirement for QC Officer, Asst. Manager at Medley Pharma
2 March 2026
Requirement for QC Officer, Asst. Manager at Medley Pharma
Candidates must have experience in analysis of raw material, finished product and Stability. Should have hands on experience on HPLC (Chromeleon), GC etc.
Felix Generics expands in Production, Warehouse, Tech. Transfer
2 March 2026
Felix Generics expands in Production, Warehouse, Tech. Transfer
Material Handling / Electronic Batch Record filling and review / Good Knowledge of SAP System / QMS / Deviation / Change Control / SOP / Daily Reports Preparation
Study Links Faulty Dopamine Packaging to Parkinson’s Progression
2 March 2026
Study Links Faulty Dopamine Packaging to Parkinson’s Progression
New research from Ludwig-Maximilians-Universität München (LMU) reveals that improper handling of the neurotransmitter dopamine within brain cells may play a critical role in worsening symptoms of Parkinson’s disease. The discovery provides fresh insights into how the disease damages neurons and points toward potential new treatment strategies.
New Study Shows Single Dose of Non-Prescribed Adderall Can Sharply Raise Heart Rate and Blood Pressure
2 March 2026
New Study Shows Single Dose of Non-Prescribed Adderall Can Sharply Raise Heart Rate and Blood Pressure
A new study by researchers at the Mayo Clinic has found that a single 25 mg dose of Adderall, when taken without a prescription, can cause significant increases in both heart rate and blood pressure in healthy young adults. The findings raise important questions about the cardiovascular effects of using this stimulant medication outside of medical supervision.
Novo Nordisk Announces Euro 432 Million Expansion of Athlone Manufacturing Facility
2 March 2026
Novo Nordisk Announces Euro 432 Million Expansion of Athlone Manufacturing Facility

March 2, 2026: In a strategic move to support global demand for oral GLP-1 therapies, Novo Nordisk has revealed plans to invest 432 million euro (approximately DKK 3.2 billion) in expanding its manufacturing operations in Athlone, Ireland.

The investment will significantly increase capacity at Novo Nordisk’s tablet production facility located in Monksland, Athlone, with upgrades aimed at broadening the company’s ability to produce current and future oral GLP-1 medicines. These medicines, used for treating conditions such as diabetes and obesity, have seen rising global demand.